Shanxi C&Y Pharmaceutical Co., Ltd. logo

Shanxi C&Y Pharmaceutical Co., Ltd. (300254)

Market Closed
11 Aug, 06:57
XSHE XSHE
¥
8. 87
+0.04
+0.453%
¥
2.96B Market Cap
- P/E Ratio
0.08% Div Yield
11.32M Volume
- Eps
¥ 8.83
Previous Close
Add Transaction
Day Range
8.7 9.01
Year Range
6.93 15.2
Want to track 300254 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300254 closed today higher at ¥8.87, an increase of 0.453% from yesterday's close, completing a monthly increase of 9.6415% or ¥0.78. Over the past 12 months, 300254 stock lost -12.1782%.
300254 is not paying dividends to its shareholders.
The last earnings report, released on Apr 09, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0395%, based on the last three reports.
Shanxi C&Y Pharmaceutical Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jul 08, 2016.
The company's stock is traded on one exchange.

300254 Chart

People also search for

Dr Corp Ltd.
¥ 23.35
-2.4237%
Sunvim Group Co., Ltd.
¥ 11.72
-3.3003%
Tibet Gaozheng Explosive Co., Ltd.
¥ 58.61
-1.6281%
Innovative Medical Management Co., Ltd.
¥ 21.24
-3.1022%
Henan Liliang Diamond Co., Ltd.
¥ 59.21
-1.366%

Shanxi C&Y Pharmaceutical Co., Ltd. (300254) FAQ

What is the stock price today?

The current price is ¥8.87.

On which exchange is it traded?

Shanxi C&Y Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300254.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.08%.

What is its market cap?

As of today, the market cap is 2.96B.

Has Shanxi C&Y Pharmaceutical Co., Ltd. ever had a stock split?

Shanxi C&Y Pharmaceutical Co., Ltd. had 2 splits and the recent split was on Jul 08, 2016.

Shanxi C&Y Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Qun Zhao CEO
XSHE Exchange
CNE1000016D0 ISIN
CN Country
1,196 Employees
11 Jul 2019 Last Dividend
8 Jul 2016 Last Split
19 Aug 2011 IPO Date

Overview

ShanXi C&Y Pharmaceutical Group Co.,LTD. is a prominent enterprise in the pharmaceutical sector, with a focus on the research, development, production, and sale of a wide range of medicine and health food products. Originally known as Shanxi C&Y Pharmaceutical Co., Ltd., it underwent a name change in September 2014 to better reflect its expansion and diversification in the pharmaceutical arena. Since its establishment in 2005, ShanXi C&Y Pharmaceutical Group Co.,LTD. has committed itself to producing high-quality pharmaceutical products and services. With headquarters in Datong, China, the company leverages its robust capabilities in R&D and manufacturing to address the diverse needs of patients and the healthcare industry at large.

Products and Services

The company’s extensive product portfolio and services include:

  • Fosfomycin tromethamine powder: A broad-spectrum antibiotic used mainly in the treatment of urinary tract infections.
  • Mezlocillin sodium sulbactam sodium for injection: A combination antibiotic employed to treat a variety of bacterial infections by preventing the bacteria from growing.
  • Ebastine tablets: These tablets serve as antihistamines for treating allergic symptoms such as runny nose, sneezing, itchy eyes, and hives.
  • Tamsulosin hydrochloride sustained release capsules: Primarily used to improve urination in men with benign prostatic hyperplasia (BPH).
  • Cinacalcet hydrochloride tablets: Employed to treat conditions such as secondary hyperparathyroidism and parathyroid carcinoma by decreasing the levels of parathyroid hormone (PTH).
  • Apixaban tablets: A type of anticoagulant that helps to prevent the formation of harmful blood clots in the legs, lungs, and heart.
  • Rivaroxaban tablets: Another anticoagulant used to treat and prevent blood clots, reducing the risk of stroke and embolism in certain patients.
  • Flouxetine hydrochloride capsules: Commonly known as antidepressants, these capsules are used to treat major depressive disorder, obsessive-compulsive disorder, and panic disorder.
  • Ambroxol hydrochloride dispersible tablets: These tablets are expectorants used to treat respiratory diseases by facilitating the removal of mucus.
  • Smectite powder: An anti-diarrheal medication that is used to treat and manage diarrhea and in some cases, certain types of IBS (Irritable Bowel Syndrome).
  • Vitamin AD drops: Supplements employed to prevent or treat deficiencies of vitamin A and D in children.
  • Baoling Yunbao oral liquid: A traditional Chinese medicine preparation commonly used to nourish and regulate the body's internal systems.

In addition to its comprehensive range of pharmaceutical products, ShanXi C&Y Pharmaceutical Group Co.,LTD. also offers a variety of medical and health services which include medical diagnosis, DNA gene preservation services, and pregnancy environment testing services. These services are geared towards enhancing overall health, aiding in disease prevention, and ensuring well-being across different life stages.

Contact Information

Address: No. 1378, Heng'an Street, Datong, China, 037010
Phone: 86 35 2611 6426